This compound is primarily utilized in the synthesis of pharmaceutical agents, particularly in the development of drugs targeting neurological and cardiovascular disorders. Its structure serves as a key intermediate in the production of inhibitors for enzymes like dipeptidyl peptidase-4 (DPP-4), which are essential in managing type 2 diabetes. Additionally, it is employed in the preparation of peptidomimetics, which mimic peptides and are used in drug design to enhance stability and bioavailability. Its role in chiral synthesis is also significant, contributing to the creation of enantiomerically pure compounds for therapeutic applications.